-
Current illicit drug use profile of orthopaedic trauma patients and its effect on hospital length of stay. Injury. 2020 Apr; 51(4):887-891.
Shymon SJ, Arthur D, Keeling P, Rashidi S, Kwong LM, Andrawis JP. PMID: 32145902.
View in:
PubMed Mentions:
8 Fields:
Translation:
Humans
-
A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxaban. Curr Med Res Opin. 2017 09; 33(9):1717-1723.
Kwong LM, Turpie AGG, Tamayo S, Peacock WF, Yuan Z, Sicignano N, Hopf KP, Patel MR. PMID: 28678604.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Postorthopedic Surgery Joint Replacement Surgery Venous Thromboembolism Prophylaxis. Hematol Oncol Clin North Am. 2016 10; 30(5):1007-18.
Kwong LM, Kimball JA. PMID: 27637304.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Opioid abuse-deterrent strategies: role of clinicians in acute pain management. Postgrad Med. 2016 Jan; 128(1):76-84.
Webster LR, Brennan MJ, Kwong LM, Levandowski R, Gudin JA. PMID: 26631936.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Real-world data confirm clinical trial outcomes for rivaroxaban in orthopaedic patients. Curr Orthop Pract. 2015 May; 26(3):299-305.
Kwong L, Turpie AG. PMID: 25973138; PMCID: PMC4420150.
View in:
PubMed Mentions:
1
-
Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery: focus on rivaroxaban. Clin Pharmacol. 2013; 5:143-8.
Kwong LM. PMID: 23946671; PMCID: PMC3739420.
View in:
PubMed Mentions:
1
-
Rivaroxaban, an oral, direct factor Xa inhibitor: a new option for thromboprophylaxis. Orthopedics. 2012 Nov; 35(11):919; discussion 919.
Kwong LM. PMID: 23127435.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Drug interactions with rivaroxaban following total joint replacement surgery. Ann Pharmacother. 2012 Sep; 46(9):1232-8.
Kwong LM, Tong LM. PMID: 22932305.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Rivaroxaban, an oral, direct factor Xa inhibitor: a new option for thromboprophylaxis. Orthopedics. 2012 Jun; 35(6):e932-8;discussion e939.
Kwong LM. PMID: 22691670.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Cost effectiveness of rivaroxaban versus enoxaparin for prevention of post-surgical venous thromboembolism from a U.S. payer's perspective. Pharmacoeconomics. 2012 Feb 01; 30(2):87-101.
Duran A, Sengupta N, Diamantopoulos A, Forster F, Kwong L, Lees M. PMID: 22187932.
View in:
PubMed Mentions:
13 Fields:
Translation:
Humans
-
Thromboprophylaxis, bleeding and post-operative prosthetic joint infection in total hip and knee arthroplasty: a comprehensive literature review. Expert Opin Pharmacother. 2012 Feb; 13(3):333-44.
Kwong LM, Kistler KD, Mills R, Wildgoose P, Klaskala W. PMID: 22220855.
View in:
PubMed Mentions:
14 Fields:
Translation:
Humans
-
Prevention of venous thromboembolism after hip or knee arthroplasty: findings from a 2008 survey of US orthopedic surgeons. J Arthroplasty. 2012 May; 27(5):659-66.e5.
Anderson FA, Huang W, Friedman RJ, Kwong LM, Lieberman JR, Pellegrini VD, Orthopaedic Surgeon's Survey Steering Committee. PMID: 22035977.
View in:
PubMed Mentions:
7 Fields:
Translation:
HumansPHPublic Health
-
Cost and outcomes associated with rivaroxaban vs enoxaparin for the prevention of postsurgical venous thromboembolism from a US payer's perspective. J Med Econ. 2011; 14(6):824-34.
Duran A, Sengupta N, Diamantopoulos A, Forster F, Kwong L, Lees M. PMID: 22023098.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Therapeutic potential of rivaroxaban in the prevention of venous thromboembolism following hip and knee replacement surgery: a review of clinical trial data. Vasc Health Risk Manag. 2011; 7:461-6.
Kwong LM. PMID: 21822393; PMCID: PMC3148419.
View in:
PubMed Mentions:
8 Fields:
Translation:
Humans
-
Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty. Am J Manag Care. 2011 Feb; 17(1 Suppl):S22-6.
Kwong LM. PMID: 21517652.
View in:
PubMed Mentions:
10 Fields:
Translation:
Humans
-
Clinical and cost outcomes of venous thromboembolism in Medicare patients undergoing total hip replacement or total knee replacement surgery. Curr Med Res Opin. 2011 Feb; 27(2):423-9.
Baser O, Supina D, Sengupta N, Wang L, Kwong L. PMID: 21192759.
View in:
PubMed Mentions:
9 Fields:
Translation:
Humans
-
Never events and related quality measures following total hip and total knee replacement. Orthopedics. 2010 Nov; 33(11):838.
Kwong LM. PMID: 21155137.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Analysis of venous thromboprophylaxis duration and outcomes in orthopedic patients. Am J Manag Care. 2010 Nov; 16(11):857-63.
Wells PS, Borah BJ, Sengupta N, Supina D, McDonald HP, Kwong LM. PMID: 21348557.
View in:
PubMed Mentions:
9 Fields:
Translation:
Humans
-
Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgery. Am J Health Syst Pharm. 2010 Sep 01; 67(17):1438-45.
Baser O, Supina D, Sengupta N, Wang L, Kwong L. PMID: 20720243.
View in:
PubMed Mentions:
8 Fields:
Translation:
Humans
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet. 2009 05 16; 373(9676):1673-80.
Turpie AG, Lassen MR, Davidson BL, Bauer KA, Gent M, Kwong LM, Cushner FD, Lotke PA, Berkowitz SD, Bandel TJ, Benson A, Misselwitz F, Fisher WD, RECORD4 Investigators. PMID: 19411100.
View in:
PubMed Mentions:
232 Fields:
Translation:
HumansCTClinical Trials
-
Decreased venous thromboembolism with injectable vs oral anticoagulation after discharge for major orthopedic surgery. J Arthroplasty. 2008 Sep; 23(6 Suppl 1):25-30.
Kwong LM, Happe LE, Horblyuk R, Farrelly E. PMID: 18722300.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery. Clin Pharmacokinet. 2008; 47(3):203-16.
Mueck W, Eriksson BI, Bauer KA, Borris L, Dahl OE, Fisher WD, Gent M, Haas S, Huisman MV, Kakkar AK, Kälebo P, Kwong LM, Misselwitz F, Turpie AG. PMID: 18307374.
View in:
PubMed Mentions:
79 Fields:
Translation:
HumansCTClinical Trials
-
Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies. Thromb Haemost. 2007 Jun; 97(6):931-7.
Fisher WD, Eriksson BI, Bauer KA, Borris L, Dahl OE, Gent M, Haas S, Homering M, Huisman MV, Kakkar AK, Kälebo P, Kwong LM, Misselwitz F, Turpie AG. PMID: 17549294.
View in:
PubMed Mentions:
10 Fields:
Translation:
Humans
-
Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis. Thromb Res. 2007; 121(1):17-24.
Shorr AF, Kwong LM, Sarnes M, Happe L, Farrelly E, Mody-Patel N. PMID: 17449088.
View in:
PubMed Mentions:
7 Fields:
Translation:
Humans
-
Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing hip fracture surgery. Value Health. 2006 Mar-Apr; 9(2):68-76.
Sullivan SD, Kwong L, Nutescu E. PMID: 16626410.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Deep vein thrombosis prophylaxis: better living through chemistry--in the affirmative. J Arthroplasty. 2005 Jun; 20(4 Suppl 2):12-4.
Kwong LM. PMID: 15991121.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Hip fracture and venous thromboembolism in the elderly. J Surg Orthop Adv. 2004; 13(3):139-48.
Kwong LM. PMID: 15559689.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Balancing new technology with established techniques. Orthopedics. 2003 Aug; 26(8 Suppl):s873-4.
Kwong LM. PMID: 12934743.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
A modular distal fixation option for proximal bone loss in revision total hip arthroplasty: a 2- to 6-year follow-up study. J Arthroplasty. 2003 Apr; 18(3 Suppl 1):94-7.
Kwong LM, Miller AJ, Lubinus P. PMID: 12730939.
View in:
PubMed Mentions:
40 Fields:
Translation:
Humans
-
Selective factor Xa inhibitors: practical guidelines for use. Am J Orthop (Belle Mead NJ). 2002 Nov; 31(11 Suppl):3.
Kwong LM. PMID: 12463576.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Thromboprophylaxis dosing: the relationship between timing of first administration, efficacy, and safety. Am J Orthop (Belle Mead NJ). 2002 Nov; 31(11 Suppl):16-20.
Kwong LM, Muntz JE. PMID: 12463579.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans